YD Bio Limited Ordinary Shares Operating Income

YD Bio Limited Ordinary Shares (YDES) currently reports a operating income of $-1.4M as of June 2025. Use the charts on this page to explore YD Bio Limited Ordinary Shares's operating income history and peer comparisons.

YD Bio Limited Ordinary Shares reported $-1.4M in operating income as of June 2025. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-1.4M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for YD Bio Limited Ordinary Shares, and consider following YDES for alerts when major investors trade the stock.

YD Bio Limited Ordinary Shares is classified in the Healthcare sector. On operating income, it currently shows $-1.4M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing YDES with unrelated industries.